ADVENTRX Pharmaceuticals (ANX) Narrows Q1 Loss of 9c/Share

ADVENTRX Pharmaceuticals (NYSE: ANX) reported Q1 EPS of ($0.09), versus ($0.13) reported last year.

For earnings history and earnings-related data on ADVENTRX Pharmaceuticals (ANX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Bank of America to acquire up to 49.9% stake in Jio Credit for ~$1.9B
• Nebius soars on second quarter revenue beat